Articles with bluebird bio
bluebird bio Completes Oncology Spin-Off Business, Establishes New Nest | BioSpace
Contact Us | bluebird bio
bluebird bio logo in transparent PNG and vectorized SVG formats
bluebird bio: Potential For 3 Gene Therapy Approvals (NASDAQ:BLUE) | Seeking Alpha
Shares plummet as bluebird bio suspends trials of sickle-cell anemia drug - Boston Business Journal
Bluebirdbio Announces The Lifting Of FDA Clinical Hold for Sickle Cell Disease And β-Thalassaemia Studies – TIF
With the pricing situation 'untenable' in Europe, bluebird will wind down its operations in the 'broken' market
Bluebird Bio Eliminating 30% of Workforce in Restructuring
Low on cash, Bluebird Bio and its gene therapies face uncertain future
Bluebird Bio Says Cash Crunch Raises 'Going Concern' Risk - Bloomberg
Somerville gene therapy firm bluebird bio nabs win with first FDA approval following split - Boston Business Journal
bluebird bio splits to create new oncology firm 2seventy bio - PMLiVE
bluebird bio (@bluebirdbio) / Twitter
Is bluebird bio a Buy? | The Motley Fool
bluebird bio: Gene Therapy Launches Could Bring Big Revenues (NASDAQ:BLUE) | Seeking Alpha
Bluebird Bio at 60 Binney
Bluebird Bio's offers sneak peek into new Seattle office (Photos) - Puget Sound Business Journal
bluebird bio, Inc - 7/24/2018 | Cowen
Bluebird Bio Finds a New Nest | High-Profile Monthly
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones and 2023 Financial Outlook Ahead of Company Presentation at 41st Annual J.P. Morgan Healthcare Conference | Business Wire
Bluebird Bio: on the cusp of a gene therapy revolution - PMLiVE
bluebird bio - YouTube
Gov. Inslee helps Bluebird Bio open new 'nest' for cancer research efforts in Seattle – GeekWire
bluebird bio | Pioneering Gene Therapies | Recode for Life
